{"id":7442,"name":"Olive Capital","slug":"olive-capital","website":"https://www.olivevc.com/","hqGeo":null,"stageFocus":[],"sectorTags":[],"excludedSectors":[],"checkSizeMin":null,"checkSizeMax":null,"thesisSummary":null,"thesisNarrative":null,"logoUrl":null,"aumUsd":null,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"Akasa","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"AI-driven automation platform for healthcare revenue cycle and operations.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Science","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Consumer health and personal care company building science-backed skincare and wellness products.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"TRLab","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Art-tech company creating digital art and NFT-based experiences in collaboration with artists and institutions.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Ender","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Software platform for managing residential real estate operations.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Pardes","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Biotechnology company developing therapeutics.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Olive Capital","companyUrl":null,"stage":"Seed-stage investor","sector":"Venture capital / angel investing","investmentYear":null,"description":"Geneva-based angel network and seed-stage venture syndicate.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Olive Resource Capital","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Investment entity distinct from Olive Capital, mentioned for disambiguation.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Olio Labs","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Company listed in secondary data sources as having an investor named Olive Capital.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Maybell","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Company listed in secondary data sources as having an investor named Olive Capital.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Sock","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Company listed in secondary data sources as having an investor named Olive Capital.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Mother Science","companyUrl":null,"stage":null,"sector":"Consumer health / personal products","investmentYear":null,"description":"Personal products / skincare company associated with Science and listed in secondary data sources.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Meliora Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Company listed in secondary data sources as having an investor named Olive Capital.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Dfns","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Company listed in secondary data sources as having an investor named Olive Capital.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"CreatorDAO","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Company listed in secondary data sources as having an investor named Olive Capital.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Galoy","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Company listed in secondary data sources as having an investor named Olive Capital.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Unitalk","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Company listed in secondary data sources as having an investor named Olive Capital.","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":1,"partners":[{"id":25448,"name":"Olivia Wang","title":"General Partner","seniority":null,"focusTags":["tech","synthetic biology","seed-stage","emergent platforms"],"linkedinUrl":"https://www.linkedin.com/in/olivia-wang-olivecapital","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsLast12Months":0},"investorType":"vc","preferredApproach":null,"prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[],"featuredIn":[],"fundraisingResources":[{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"},{"slug":"what-vcs-actually-look-for-pitch-deck","title":"What VCs Actually Look for in a Pitch Deck"},{"slug":"find-right-pre-seed-investors-b2b-saas","title":"How to Find the Right Pre-Seed Investors for Your B2B SaaS Startup"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":null}